比较风险感知在乳腺癌预防计划中的独特作用。
The distinct role of comparative risk perceptions in a breast cancer prevention program.
机构信息
Department of Psychology, Grand Valley State University, Allendale, MI 49401, USA.
出版信息
Ann Behav Med. 2011 Oct;42(2):262-8. doi: 10.1007/s12160-011-9287-8.
Abstract
BACKGROUND
Comparative risk perceptions may rival other types of information in terms of effects on health behavior decisions.
PURPOSE
We examined associations between comparative risk perceptions, affect, and behavior while controlling for absolute risk perceptions and actual risk.
METHODS
Women at an increased risk of breast cancer participated in a program to learn about tamoxifen which can reduce the risk of breast cancer. They reported comparative risk perceptions of breast cancer and completed measures of anxiety, knowledge, and tamoxifen-related behavior intentions. Three months later, the women reported their behavior.
RESULTS
Comparative risk perceptions were positively correlated with anxiety, knowledge, intentions, and behavior 3 months later. After controlling for participants' actual risk of breast cancer and absolute risk perceptions, comparative risk perceptions predicted anxiety and knowledge, but not intentions or behavior.
CONCLUSIONS
Comparative risk perceptions can affect patient outcomes like anxiety and knowledge independently of absolute risk perceptions and actual risk information.
摘要
背景
比较风险感知可能会与其他类型的信息一样，对健康行为决策产生影响。
目的
在控制绝对风险感知和实际风险的情况下，我们检验了比较风险感知、情感与行为之间的关联。
方法
患有乳腺癌风险增加的女性参与了一个关于他莫昔芬的项目，该药物可以降低乳腺癌的风险。她们报告了对乳腺癌的比较风险感知，并完成了焦虑、知识和他莫昔芬相关行为意向的测量。3 个月后，女性报告了她们的行为。
结果
比较风险感知与 3 个月后的焦虑、知识、意向和行为呈正相关。在控制了参与者的实际乳腺癌风险和绝对风险感知后，比较风险感知可以预测焦虑和知识，但不能预测意向或行为。
结论
比较风险感知可以独立于绝对风险感知和实际风险信息，影响患者的焦虑和知识等结果。
相似文献
1
The distinct role of comparative risk perceptions in a breast cancer prevention program.比较风险感知在乳腺癌预防计划中的独特作用。
Ann Behav Med. 2011 Oct;42(2):262-8. doi: 10.1007/s12160-011-9287-8.
2
Breast cancer anxiety's associations with responses to a chemoprevention decision aid.乳腺癌焦虑与化学预防决策辅助工具反应的关联。
Soc Sci Med. 2013 Jan;77:13-9. doi: 10.1016/j.socscimed.2012.10.009. Epub 2012 Nov 2.
3
Trait anxiety, symptom perceptions, and illness-related responses among women with breast cancer in remission during a tamoxifen clinical trial.他莫昔芬临床试验期间缓解期乳腺癌女性的特质焦虑、症状认知及疾病相关反应
Health Psychol. 1998 Sep;17(5):459-69. doi: 10.1037//0278-6133.17.5.459.
4
Women's perceptions of breast cancer risk: how you ask matters.女性对乳腺癌风险的认知：提问方式很重要。
Med Decis Making. 1999 Jul-Sep;19(3):221-9. doi: 10.1177/0272989X9901900301.
5
Can risk and illness perceptions predict breast cancer worry in healthy women?风险和疾病认知能否预测健康女性对乳腺癌的担忧？
J Health Psychol. 2016 Sep;21(9):2052-62. doi: 10.1177/1359105315570984. Epub 2015 Feb 23.
6
Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.乳腺癌高危女性使用他莫昔芬的决策：临床和心理因素
J Clin Oncol. 2004 Dec 15;22(24):4951-7. doi: 10.1200/JCO.2004.05.192. Epub 2004 Dec 14.
7
Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.评估他莫昔芬风险的女性偏好（POWER）研究：关于他莫昔芬降低乳腺癌风险的偏好
Cancer. 2005 May 15;103(10):1996-2005. doi: 10.1002/cncr.20981.
8
Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid.女性对服用他莫昔芬和雷洛昔芬预防乳腺癌的兴趣：对量身定制的决策辅助工具的反应。
Breast Cancer Res Treat. 2011 Jun;127(3):681-8. doi: 10.1007/s10549-011-1450-1. Epub 2011 Mar 26.
9
Relationships among breast cancer perceived absolute risk, comparative risk, and worries.乳腺癌感知绝对风险、比较风险与担忧之间的关系。
Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):973-5.
10
Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy.考虑行乳腺癌预防治疗的女性对他莫昔芬潜在危害和获益的认知。
Cancer Prev Res (Phila). 2020 Apr;13(4):411-422. doi: 10.1158/1940-6207.CAPR-19-0424. Epub 2020 Jan 27.
引用本文的文献
1
Worry about prostate cancer and risk perception among middle-aged men: results from the PROBASE trial.中年男性对前列腺癌的担忧及风险认知：PROBASE试验的结果
J Behav Med. 2025 Jun;48(3):464-477. doi: 10.1007/s10865-025-00559-w. Epub 2025 Mar 5.
2
Risk-management decision-making data from a community-based sample of racially diverse women at high risk of breast cancer: rationale, methods, and sample characteristics of the Daughter Sister Mother Project survey.基于社区的、种族多样的乳腺癌高风险女性样本的风险管理决策数据：女儿姐妹母亲项目调查的基本原理、方法和样本特征。
Breast Cancer Res. 2024 Jan 11;26(1):8. doi: 10.1186/s13058-023-01753-x.
3
Associations between COVID-19 risk perceptions, behavior intentions and worry.2019冠状病毒病风险认知、行为意图与担忧之间的关联
Health Psychol Rep. 2022 Mar 21;10(2):139-148. doi: 10.5114/hpr.2022.114477. eCollection 2022.
4
Does the disclosure of medical insurance information affect patients' willingness to adopt the diagnosis related groups system.医疗保险信息披露是否会影响患者采用按疾病诊断相关分组付费制度的意愿。
Front Public Health. 2023 Aug 21;11:1136178. doi: 10.3389/fpubh.2023.1136178. eCollection 2023.
5
Which measures of perceived vulnerability predict protective intentions-and when?哪些感知到的脆弱性指标能够预测保护意图，以及在何时预测？
J Behav Med. 2023 Dec;46(6):912-929. doi: 10.1007/s10865-023-00439-1. Epub 2023 Aug 9.
6
Specifying Future Behavior When Assessing Risk Perceptions: Implications for Measurement and Theory.指定评估风险感知时的未来行为：对测量和理论的启示。
Med Decis Making. 2019 Nov;39(8):986-997. doi: 10.1177/0272989X19879704. Epub 2019 Oct 24.
7
Physical activity: the relative associations with cognitive and affective risk beliefs.身体活动：与认知和情感风险信念的相对关联。
Psychol Health. 2019 Nov;34(11):1294-1313. doi: 10.1080/08870446.2019.1604954. Epub 2019 Apr 23.
8
Communicating risk of medication side-effects: role of communication format on risk perception.药物副作用风险的沟通：沟通形式对风险认知的作用。
Pharm Pract (Granada). 2018 Apr-Jun;16(2):1174. doi: 10.18549/PharmPract.2018.02.1174. Epub 2018 Jun 27.
9
Combining risk communication strategies to simultaneously convey the risks of four diseases associated with physical inactivity to socio-demographically diverse populations.结合风险沟通策略，同时向社会人口统计学上不同的人群传达与身体活动不足相关的四种疾病的风险。
J Behav Med. 2018 Jun;41(3):318-332. doi: 10.1007/s10865-017-9894-3. Epub 2017 Oct 13.
10
Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.乳腺癌风险增加的女性使用他莫昔芬作为降低风险药物的动机和障碍：一项系统的文献综述
Hered Cancer Clin Pract. 2017 Sep 20;15:14. doi: 10.1186/s13053-017-0075-8. eCollection 2017.
本文引用的文献
1
Flawed Self-Assessment: Implications for Health, Education, and the Workplace.有缺陷的自我评估：对健康、教育和工作场所的影响。
Psychol Sci Public Interest. 2004 Dec;5(3):69-106. doi: 10.1111/j.1529-1006.2004.00018.x. Epub 2004 Dec 1.
2
Perceived and actual breast cancer risk: optimistic and pessimistic biases.感知和实际乳腺癌风险：乐观和悲观偏见。
J Health Psychol. 1998 Apr;3(2):181-93. doi: 10.1177/135910539800300203.
3
Risk communication and worry about breast cancer.风险沟通与乳腺癌担忧。
Psychol Health Med. 2003 Nov;8(4):379-89. doi: 10.1080/13548500310001604513.
4
Worry as a moderator of the association between risk perceptions and quitting intentions in young adult and adult smokers.担忧作为风险认知与年轻成年和成年吸烟者戒烟意愿之间关联的调节因素。
Ann Behav Med. 2009 Dec;38(3):256-61. doi: 10.1007/s12160-009-9143-2.
5
Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.女性对用于乳腺癌预防的他莫昔芬的决策：对定制决策辅助的回应。
Breast Cancer Res Treat. 2010 Feb;119(3):613-20. doi: 10.1007/s10549-009-0618-4.
6
Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs.在他莫昔芬预防决策辅助工具中传达副作用风险：象形图的去偏影响。
Patient Educ Couns. 2008 Nov;73(2):209-14. doi: 10.1016/j.pec.2008.05.010.
7
"If I'm better than average, then I'm ok?": Comparative information influences beliefs about risk and benefits.“如果我比平均水平好，那么我就没事了？”：比较信息会影响对风险和益处的看法。
Patient Educ Couns. 2007 Dec;69(1-3):140-4. doi: 10.1016/j.pec.2007.08.008. Epub 2007 Oct 17.
8
Cancer risk elicitation and communication: lessons from the psychology of risk perception.癌症风险的引出与沟通：风险认知心理学的启示
CA Cancer J Clin. 2007 May-Jun;57(3):147-67. doi: 10.3322/canjclin.57.3.147.
9
Measuring perceptions of breast cancer risk.测量对乳腺癌风险的认知。
Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1893-8. doi: 10.1158/1055-9965.EPI-05-0482.
10
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.他莫昔芬与雷洛昔芬对发生浸润性乳腺癌及其他疾病转归风险的影响：国家外科辅助乳腺和肠道项目（NSABP）他莫昔芬与雷洛昔芬研究（STAR）P-2试验
JAMA. 2006 Jun 21;295(23):2727-41. doi: 10.1001/jama.295.23.joc60074. Epub 2006 Jun 5.
Zotero 插件